BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2220670)

  • 1. Safety and cost-containment data that advocate abbreviated pretransfusion testing.
    Cordle DG; Strauss RG; Snyder EL; Floss AM
    Am J Clin Pathol; 1990 Oct; 94(4):428-31. PubMed ID: 2220670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the indirect antiglobulin crossmatch justified?
    Peterson DM; Roxby DJ; Seshadri R
    Pathology; 1987 Apr; 19(2):121-3. PubMed ID: 3502613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative utility of the autologous control and the antiglobulin test phase of the crossmatch.
    Perkins JT; Arruza M; Fong K; Sosler SD; Saporito C
    Transfusion; 1990; 30(6):503-7. PubMed ID: 2378021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a cost-effective crossmatch protocol.
    Shulman IA; Nelson JM; Kent DR; Jacobs VL; Nakayama RK; Malone SA
    JAMA; 1985 Jul; 254(1):93-5. PubMed ID: 3999355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of clinically significant antibodies in patients undergoing elective surgery in a Nigerian teaching hospital: A case for the type and screen method.
    Obi EI; Pughikumo OC; Korubo KI; Ejele AO
    Niger J Clin Pract; 2020 Feb; 23(2):138-146. PubMed ID: 32031086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a manual hexadimethrine bromide-antiglobulin test with saline- and albumin-antiglobulin tests for pretransfusion testing.
    Mintz PD; Anderson G
    Transfusion; 1987; 27(2):134-7. PubMed ID: 3824470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic verification of donor-recipient compatibility: the computer crossmatch.
    Butch SH; Judd WJ; Steiner EA; Stoe M; Oberman HA
    Transfusion; 1994 Feb; 34(2):105-9. PubMed ID: 8310478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion Preparedness in the Labor and Delivery Unit: An Initiative to Improve Safety and Cost.
    Benson AE; Metcalf RA; Cail K; Rollins MD; Warrick CM; Falkner D; Clark EAS; Nelson RE; Einerson BD
    Obstet Gynecol; 2021 Nov; 138(5):788-794. PubMed ID: 34619726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population.
    Mathur A; Jindal A; Tiwari AK; Bhuyan D; Jagannathan L; Sawant RB; Basu S; Reddy M; Datta SS
    Immunohematology; 2022 Sep; 38(3):100-105. PubMed ID: 36190198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suitability of preadmission blood samples for pretransfusion testing in elective surgery.
    Marosszeky S; McDonald S; Sutherland J; Haysom H; Haeusler M; Sellings C; Metz J; McGrath KM
    Transfusion; 1997 Sep; 37(9):910-2. PubMed ID: 9308636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reappraisal of pre-transfusion testing procedures in a hospital blood bank.
    Lown JA; Barr AL; Jackson JM
    Pathology; 1985 Jul; 17(3):489-92. PubMed ID: 4069768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.
    Anu KD; Pahuja S; Sharma G
    Asian J Transfus Sci; 2022; 16(1):83-88. PubMed ID: 36199420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Gupta GK; Raina V
    Asian J Transfus Sci; 2017; 11(1):40-44. PubMed ID: 28316439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposal for compatibility testing incorporating the manual hexadimethrine bromide (Polybrene) test.
    Steane EA; Steane SM; Montgomery SR; Pearson JR
    Transfusion; 1985; 25(6):540-4. PubMed ID: 4071598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransfusion blood group serology. Limited value of the antiglobulin phase of the crossmatch when a careful screening test for unexpected antibodies is performed.
    Heistø H
    Transfusion; 1979; 19(6):761-3. PubMed ID: 118557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.